There were a number of problems with the protocol, but the IRB eventually approved the protocol as a more than minimal risk study at a duly constituted full IRB committee review on February 15, 2010. Accrual and treatment are planned to continue through 2011. Which of the following best describes IRB continuation review requirements for this study? The continuation review can be conducted by the IRB chair only. The IRB may extend the deadline for continuing review by 30 days. After that, the research must cease. The continuation review may be conducted by a voting member of the IRB, delegated by the chair. The research must be re-reviewed by the full IRB committee on or before February 14, 2011.